ResMed Inc. to Present at Upcoming Investor Conferences

SAN DIEGO, Aug. 10 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that they will be presenting at three upcoming investor conferences.

    --  Kieran Gallahue, President and CEO will be presenting at the Canaccord
        Adams Global Growth Conference at the Intercontinental Boston Hotel in
        Boston on August 12, 2009 at 9:00 a.m. US Eastern Time
    --  David Pendarvis, SVP, Organization Development and General Counsel will
        be presenting at the Morgan Stanley Global Healthcare Conference at the
        Grand Hyatt in NYC on September 15, 2009

    --  David Pendarvis will present at the UBS Global Life Sciences Conference
        also at the Grand Hyatt in NYC on September 22, 2009

Actual presentation times for the latter two conferences will be able to be found on our website in the "Investor" section under "Event Calendar" in the near future as they are confirmed.

The Company's presentations will be webcast. To access the live webcast or the archived webcast of the presentation, please log onto the Company's website at http://investor.resmed.com. Further information can be obtained by contacting Constance Bienfait at ResMed Inc., San Diego, at +1(858) 836-5971 or by visiting the Company's multilingual Web site at www.resmed.com.

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.

SOURCE ResMed Inc.

Released August 10, 2009